TULA® DUAL

Product catalog summary

Overview of Bladder Cancer:
Bladder cancer presents a significant economic burden of €4.9 billion across the EU. It is the 9th most commonly diagnosed cancer globally and the 5th in Europe, with 1.9 million people living with the disease worldwide and over 570,000 new cases annually. Notably, 75% of urothelial bladder tumors are non-muscle invasive bladder cancer (NMIBC).

TULA® DUAL Laser Technology:
The TULA® DUAL system by biolitec® utilizes dual wavelengths of 980 nm and 1470 nm, offering high absorption in water and hemoglobin. This technology is designed for minimally invasive treatments, providing efficient intra and postoperative results. The dual diode lasers and high-quality fiber optics ensure safe and cost-effective procedures.

Technical Specifications:
The LEONARDO® Mini Dual model features:

Power/Wavelength: 11 W (980 nm) / 5 W (1470 nm)
Fiber diameter: ≥ 360 μm
Aiming beam: 635 nm, max. 4 mW
Treatment modes: Continuous Wave (CW), pulse mode
Pulse duration/break: 0.01 – 180 sec
Power supply: 110 – 240 VAC, 50 – 60 Hz
Dimensions: 6 cm × 9 cm × 21.5 cm
Weight: 900 g

It includes safety goggles, a foot switch, power cord, and manual.

Advantages of TULA® DUAL:

Prevents obturator nerve reflex
Specially designed fibers for enhanced visibility
Controlled penetration depth with minimal thermal spread
Atraumatic fiber tip for smooth insertion
Dual-wavelength for matched tumor penetration depth
Office procedure without anesthesia
Compatible with single and reusable cystoscopes
Clinically proven non-inferiority to TURBT
Hexagonal fiber core for homogeneous treatment
Cost-efficient and resource-saving
Suitable for anticoagulated patients
Low pain scores with excellent tolerability

Contact Information:
For more information on minimally invasive laser therapies, contact biolitec GmbH at [email protected] or visit their local partners.

Catalog excerpts

Bladder Tumors (NMIBC) Technology meets Anatomy

Open the catalog to page 1

TULA® DUAL ‒ Laser Technology Staying true to its tradition of pioneering minimally invasive treatments, biolitec® combines dual wavelengths of 980 nm and 1470 nm to deliver excellent and efficient intra and postoperative results. Dual diode lasers, paired with high-quality fiber optics, ensure safe and cost-effective procedures for both healthcare professionals and patients. THE IMPACT OF BLADDER CANCER most common cancer in Europe people live with bladder cancer worldwide LEONARDO® DUAL with specially designed fibers combines the wavelengths of 980 nm and 1470 nm with high absorption in water...

Open the catalog to page 2

NON MUSCLE INVASIVE BLADDER TUMORS NMIBC Non–muscle-invasive bladder tumors typically have a high recurrence rate, leading to multiple treatments. Elderly patients with multiple morbidities are often not fit for conventional treatment under general anesthesia. TULA® DUAL offers a technique using flexible cystoscopy for the treatment of bladder tumors under local or even no anesthesia in outpatient settings. The TULA® slim fiber allows for greater scope flexibility, which is essential for bladder neck procedures on the J manoeuvre with flexible cystoscopes. This is particularly helpful when a...

Open the catalog to page 3

To Learn More About a Whole New World of Minimally Invasive Laser Therapies Aesthetics Thyroid Treatment Thoracic Surgery Orthopaedics & Pain Management Aesthetics Urology Orthopaedics & Pain Management Phlebology biolitec GmbH Untere Viaduktgasse 6/9 A-1030 Wien [email protected] Legal Manufacturer CeramOptec GmbH Siemensstr. 44 53121 Bonn Find your local biolitec® partner © biolitec®, Rev. E 062026, 411420000, Urology Brochure TULA® EN / Layout: 6grad51.de

Open the catalog to page 4

TULA® DUAL

TULA® DUAL

Catalog excerpts

All Biolitec catalogs and technical brochures

Archived catalogs